Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy
compared to bronchodilator therapy on the course of asthma, particularly on lung function and
bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
Phase:
Phase 3
Details
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborators:
CAMP Steering Committee National Heart, Lung, and Blood Institute (NHLBI)